Vice President, General Manager & Campus Lead, Devens

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it. Position Summary The General Manager, Devens is the senior leader accountable for the end-to-end performance, compliance, and strategic direction of BMS’s large-scale commercial biologics Global Business Unit (GBU) operations at Devens, and serves as the Campus Lead for the full Devens site, spanning both the GBU Biologics organization and the Cell Therapy business unit. This role oversees all GBU Biologics site operations at Devens – from cell culture and manufacturing sciences & technology (MS&T) to large-scale commercial drug substance production – with full accountability for talent development, safety, quality, regulatory compliance, supply reliability, and cost management across the Biologics organization. As Campus Lead, the General Manager also owns end-to-end site services and shared infrastructure – Site Engineering, Environmental Health & Safety, Security, and Facilities – that support both the GBU Biologics and Cell Therapy business units operating on the Devens campus, ensuring both organizations have the capacity, capabilities, and infrastructure to deliver on their respective missions. A defining focus of this role over the next several years is leading the transformation and integration of the GBU Biologics and Cell Therapy business units at Devens – building a single, unified campus operating model, governance structure, and culture that harmonizes site services, talent, and ways of working across both modalities. This includes championing innovative, digitally enabled and AI-driven transformation – advanced analytics, automation, digital twins, and other Industry 4.0 capabilities – to reimagine site processes, accelerate integration, and establish Devens as a “smart campus” that delivers sustainable competitive advantage. The General Manager also serves as the primary representative of the Devens campus both within the global manufacturing network (driving adoption of world-class standards and sharing best practices across BMS’s network of manufacturing sites) and externally (engaging with regulatory authorities, government officials, industry partners, and the local community to uphold the Company’s reputation and advance strategic initiatives). This position is pivotal in ensuring that the Devens campus remains a world-class, innovative biologics and cell therapy manufacturing hub that reliably delivers life-saving medicines to patients while successfully transforming into a single, integrated, future-ready campus. Key Responsibilities In this role, the General Manager will provide strategic, technical, and operational leadership across a broad range of functional domains and both business units at Devens. Key responsibilities include: Strategic & Enterprise Leadership: Develop and execute Devens’ long-range strategy in alignment with BMS’s global manufacturing network, GBU pipeline plans, and Cell Therapy growth objectives. Ensure the site’s capabilities evolve in step with enterprise needs, including readiness for new biologics modalities and Cell Therapy platform expansion. Represent Devens in Product Development and Supply (PDS) and Cell Therapy governance forums, and in enterprise-wide manufacturing network forums (e.g., Factory Level Optimized Work (FLOW), best practice standardization). Anticipate industry trends and build site-level strategies and contingency plans that maintain a competitive edge for both business units. Biologics Manufacturing Operations & Technical Excellence: Oversee all GBU Biologics drug substance manufacturing operations at Devens, ensuring reliable supply of high-quality biologics to meet commercial demand and clinical pipeline needs. Maintain rigorous standards for safety, quality, and efficiency across cell culture, purification, and manufacturing sciences & technology (MS&T) operations. Drive effective technology transfer and scale-up of new processes, enabling rapid industrialization of new biologic therapies while minimizing risk and optimizing time-to-market. Campus Leadership & Cross-Business Unit Governance: Serve as the Campus Lead for the full Devens site, with end-to-end accountability for shared infrastructure and services – Site Engineering, EHS, Security, and Facilities – that enable both the GBU Biologics and Cell Therapy business units to operate safely, reliably, and efficiently. Establish and chair a unified campus governance model and leadership forum that brings GBU Biologics and Cell Therapy leadership together to align priorities, resolve cross-business unit resource and capacity trade-offs, and represent one Devens voice to the enterprise. Site Transformation & Business Unit Integration: Lead the multi-year transformation and integration of the GBU Biologics and Cell Therapy business units at Devens into a single, unified campus operating model. Design and execute the integration roadmap – covering organizational structure, ways of working, shared services, talent, and culture – in close partnership with GBU and Cell Therapy senior leadership. Serve as the primary change agent for the transformation, building momentum, managing risk, and ensuring business continuity for both business units throughout the integration period. Quality, EHS & Regulatory Compliance: Champion a world-class safety and quality culture across the full Devens campus. Ensure full compliance with global GMP standards, EHS regulations, and all regulatory requirements across biologics and cell therapy manufacturing processes. Serve as the site’s executive sponsor during regulatory inspections and audits, maintaining a state of constant inspection readiness. Model and enforce behaviors that prioritize patient safety, product quality, and a safe working environment, aiming for zero safety incidents and the highest levels of regulatory confidence. Digital Transformation & AI-Driven Innovation: Lead Devens’ journey toward becoming a smart, digitally enabled campus. Drive the adoption of AI/ML, predictive analytics, automation, robotics, and other Industry 4.0 technologies to improve manufacturing efficiency, agility, and reliability, and to accelerate the site’s transformation and integration agenda. Champion AI and advanced analytics for predictive maintenance, yield optimization, and proactive deviation management. Partner with BMS Digital and IT teams to pilot and scale enterprise digital initiatives, ensuring the workforce is trained and adaptable to new d